Staff Spotlight: Maria Anitan, MD

Maria Anitan, MD, is Global Head of Pharmacovigilance at Med Communications. Maria is an experienced pharmaceutical industry professional with more than 15 years in leadership roles covering pharmacovigilance, medical affairs, healthcare compliance, patient advocacy, General Data Protection Regulation (GDPR), medical education and communication, and clinical development, which she has practiced in the United States and Europe.

Maria graduated as a Medical Doctor in General Medicine from “Iuliu Hatieganu” Medicine and Pharmacy University in Cluj-Napoca, Romania. She joined the pharmaceutical industry from clinical practice and held different positions in Eli Lilly, Genzyme-Sanofi, UCB, and Ipsen, being involved in or leading multiple cross-functional projects in the areas of rare diseases, neurology, oncology, bone marrow transplant, and hematology. She is a subject matter expert for pharmacovigilance issues, regulatory interpretation and best practices, and management of safety data and analysis in both clinical trials and post-marketing around the world.

Maria is highly respected in the field of pharmacovigilance, and Med Communications is grateful to have her leading our PV team. Contact her today at 877-202-3759 or https://medcommunications.com/contact-us/.